Clinical Trial Hits Of 2025

 
• By Alexandra Shimmings
  
perspectives 2026
Arrows hitting targets
FDA's Office of Generic Drugs understands the importance of hitting the mark on user fee goal dates. (Shutterstock)

More from Scrip Perspectives

More from Anticancer